收稿日期: 2023-11-15
网络出版日期: 2024-05-21
基金资助
国家自然科学基金项目(82160080);云南省临床医学研究中心子课题专项基金(202102AA310069);云南省“兴滇英才支持计划项目”(YNWR-MY-2020-011)
Research progress in atrial arrhythmia recurrence after catheter ablation for atrial fibrillation
Received date: 2023-11-15
Online published: 2024-05-21
念思琦 , 赵璐露 , 华宝桐 . 心房颤动导管消融术后房性心律失常复发的研究进展[J]. 实用医学杂志, 2024 , 40(10) : 1338 -1343 . DOI: 10.3969/j.issn.1006-5725.2024.10.002
Atrial fibrillation （AF） is one of the most common arrhythmias in clinical practice， with a high rate of death and disability. In recent years， with the help of catheter ablation and other techniques， some patients can maintain sinus rhythm， achieving the goal of eradicating AF. However， the recurrence rate of atrial arrhythmias after the first radiofrequency ablation is still around 20% to 30% at present， and the efficacy of radiofrequency ablation for AF has not yet reached the expected level. Exploring the risk factors for recurrence after ablation， intervening and continuously and improving the catheter ablation procedure are extremely important for reducing the risk of recurrence. This article reviews the latest research progress on the recurrence of atrial arrhythmias after catheter ablation for AF.
| 1 | DU X， GUO L， XIA S， et al. Atrial fibrillation prevalence， awareness and managem-ent in a nationwide survey of adults in China ［J］. Heart， 2021， 107（7）：535-541. doi:10.1136/heartjnl-2020-317915 |
| 2 | HINDRICKS G， POTPARA T， DAGRES N， et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio- Thoracic Surgery （EACTS）： the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology （ESC） developed with the special contribution of the European Heart Rhythm Association （EHRA） of the ESC ［J］. Eur Heart J， 2021， 42（5）：373-498. doi:10.1093/eurheartj/ehaa798 |
| 3 | PACKER D L， MARK D B， ROBB R A， et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality， Stroke， Bleeding， and Cardiac Arrest Among Patients With Atrial Fibrillation： The CABANA Randomized Clinical Trial ［J］. JAMA， 2019， 321（13）：1261-1274. |
| 4 | 中国医师协会心律学专业委员会，中华医学会心电生理和起搏分会，经冷冻球囊导管消融心房颤动中国专家共识 ［J］.中国心脏起搏与心电生理杂志， 2020，34（2）：95-108. |
| 5 | WAZNI O M， DANDAMUDI G， SOOD N . et al. Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation ［J］. N Engl J Med， 2021， 384（4）：316-324. doi:10.1056/nejmoa2029554 |
| 6 | HONARBAKHSH S， MARTIN C A， MESQUITA J， et al. Atrial fibrillation cryoablation is an effective day case treatment： the UK PolarX vs. Arctic Front Advance experience ［J］. Europace， 2023， 25（11）：euad286. doi:10.1093/europace/euad286 |
| 7 | MORAN D， DE R V， DE ASMUNDIS C， et al. Second generation cryoballoon ablation for atrial fibrillation in young adults： midterm outcome in patients under 40 years of age ［J］. Europace， 2018， 20（2）：295-300. doi:10.1093/europace/euw395 |
| 8 | CHAHINE Y， AFROZE T， BIFULCO S F， et al.Cryoballoon temperature parameters during cryoballoon ablation predict pulmonary vein reconnection and atrial fibrillation recurrence ［J］. J Interv Card Electrophysiol， 2023， 66（6）：1367-1373. doi:10.1007/s10840-022-01429-0 |
| 9 | TURAGAM M K， NEUZIL P， SCHMIDT B， et al. Safety and Effectiveness of Pulse Field Ablation to Treat Atrial Fibrillation： One-Year Outcomes From the MANIFEST-PF Registry ［J］. Circulation， 2023， 148（1）：35-46. doi:10.1161/circulationaha.123.064959 |
| 10 | SCHMIDT B， BORDIGNONS， TOHOKU S， et al. 5S Study： Safe and Simple Single Shot Pulmonary Vein Isolation With Pulsed Field Ablation Using Sedation ［J］. Circ Arrhythm Electrophysiol， 2022， 15（6）：e010817. doi:10.1161/circep.121.010817 |
| 11 | KAWAMURA I， NEUZIL P， SHIVAMURTHY P， et al. How does the level of pulmonary venous isolation compare between pulsed field ablation and thermal energy ablation （radiofrequency， cryo， or laser）？ ［J］. Europace， 2021， 23（11）：1757-1766. doi:10.1093/europace/euab150 |
| 12 | FU K， ZHU X， CHU H， et al. Re-recognize early recurrence of persistent atrial fibrillation ［J］. Front Cardiovasc Med， 2023， 10：1145695. doi:10.3389/fcvm.2023.1145695 |
| 13 | KIM Y G， BOO K Y， ChOI J I， et al. Early Recurrence Is Reliable Predictor of Late Recurrence After Radiofrequency Catheter Ablation of Atrial Fibrillation ［J］. JACC Clin Electrophysiol， 2021， 7（3）： 343-351. doi:10.1016/j.jacep.2020.09.029 |
| 14 | FUJISAWA T， KAWAKAMI H， NAGAI T，et al. Premature atrial contraction immediately after catheter ablation was associated with late recurrence of atrial fibrillation［J］. Pacing Clin Electrophysiol， 2023， 46（2）：152-160. doi:10.1111/pace.14648 |
| 15 | LI G， WANG X， HAN J J， et al. Development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablation ［J］. Front Cardiovasc Med， 2022， 9：1042573. doi:10.3389/fcvm.2022.1042573 |
| 16 | WINKLE R A， MEAD R H， ENGEL G， et al. Very long term outcomes of atrial fibrillation ablation ［J］. Heart Rhythm， 2023， 20（5）：680-688. doi:10.1016/j.hrthm.2023.02.002 |
| 17 | MUJOVIC N M， MARINKOVIC M M， MARKOVIC N， et al. Risk factors for late reconnections after circumferential pulmonary vein isolation guided by lesion size index-Data from repeat invasive electrophysiology procedure ［J］. Front Cardiovasc Med， 2023，9：986207. doi:10.3389/fcvm.2022.986207 |
| 18 | VAN DER H C A J， WEBERNDORFER V， VROOMEN M， et al. Hybrid Ablation Versus Repeated Catheter Ablation in Persistent Atrial Fibrillation： A Randomized Controlled Trial ［J］. JACC Clin Electrophysiol， 2023， 9（7 Pt 2）：1013-1023. doi:10.1016/j.jacep.2022.12.011 |
| 19 | VAN DER H C A J， WEBERNDORFER V， VROOMEN M， et al. Reply： Hybrid Ablation for Persistent Atrial Fibrillation： The Approach Matters ［J］. JACC Clin Electrophysiol， 2023， 9（7 Pt 2）：1195. doi:10.1016/j.jacep.2023.03.019 |
| 20 | STEFANO B， ILARIA M， SHOTA T， et al. Efficacy and safety in patients treated with a novel radiofrequency balloon： a two centres experience from the AURORA collaboration ［J］. Europace， 2023， 25（5）：euad106. doi:10.1093/europace/euad106 |
| 21 | DE G Y， SOFANOS D， TIJSKENS M， et al. The absence of real-time pulmonary vein isolation during cryoballoon ablation is associated with atrial fibrillation recurrence and pulmonary vein reconnection： Insights from the Middelheim-PVI Registry 2 ［J］. J Interv Card Electrophysiol， 2023，66（9）：2091-2101. doi:10.1007/s10840-023-01538-4 |
| 22 | PARK C S， KIM H， LEE S R， et al. Prognostic implication of early recurrence after cryoballoon ablation in patients with atrial fibrillation ［J］. J Interv Card Electrophysiol， 2023，67（2）：285-292. doi:10.1007/s10840-023-01555-3 |
| 23 | KUEFFER T， STEFANOVA A， MADAFFAIR A， et al. Pulmonary vein isolation durability and lesion regression in patients with recurrent arrhythmia after pulsed-field ablation ［J］. J Interv Card Electrophysiol， 2023，67（3）：503-511. doi:10.1007/s10840-023-01608-7 |
| 24 | KISTLER P M， CHIENG D， SUGUMAR H， et al. Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation： The CAPLA Randomized Clinical Trial ［J］. JAMA， 2023， 329（2）：127-135. doi:10.1001/jama.2023.5285 |
| 25 | CHIENG D， SUGUMAR H， HUNT A， et al. Impact of Posterior Left Atrial Voltage on Ablation Outcomes in Persistent Atrial Fibrillation： CAPLA Substudy ［J］. JACC Clin Electrophysiol， 2023， 9（11）：2291-2299. doi:10.1016/j.jacep.2023.08.002 |
| 26 | BENALI K， BARRE V， HERMIDA A，et al.Recurrences of Atrial Fibrillation Despite Durable Pulmonary Vein Isolation： The PARTY-PVI Study ［J］. Circ Arrhythm Electrophysiol， 2023， 16（3）：e011354. doi:10.1161/circep.122.011354 |
| 27 | ISGANDAROVA K， BERGAU L， EL H M， et al. Impact of pulmonary vein anatomy and ostial dimensions on long-term outcome after single-shot device-guided cryoablation for paroxysmal atrial fibrillation ［J］. J Interv Card Electrophysiol， 2023， 66（9）：2125-2133. doi:10.1007/s10840-023-01554-4 |
| 28 | SZEGEDI N， VECSEY-NAGY M， SIMON J， et al. Orientation of the right superior pulmonary vein affects outcome after pulmonary vein isolation ［J］. Eur Heart J Cardiovasc Imaging， 2022， 23（4）：515-523. doi:10.1093/ehjci/jeab041 |
| 29 | PONGRATZ J， RIESS L， HARTL S， et al. Left atrial appendage volume is an independent predictor of atrial arrhythmia recurrence following cryoballoon pulmonary vein isolation in persistent atrial fibrillation ［J］. Front. Cardiovasc， 2023， 10：1190860. doi:10.3389/fcvm.2023.1190860 |
| 30 | SIMON J， El MAHDIUI M， SMIT J M， et al. Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation［J］. Clin Cardiol， 2022， 45（3）：273-281. doi:10.1002/clc.23748 |
| 31 | OSMANCIK P， HERMAN D， NEUZIL P， et al. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation ［J］. J Am Coll Cardiol， 2022， 79（1）：1-14. doi:10.1016/j.jacc.2021.10.023 |
| 32 | KHAN H R， YAKUPOGLU H Y， KRALJ-HANS I， et al. Left Atrial Function Predicts Atrial Arrhythmia Recurrence Following Ablation of Long-Standing Persistent Atrial Fibrillation ［J］. Circ Cardiovasc Imaging， 2023， 16（6）：e015352. doi:10.1161/circimaging.123.015352 |
| 33 | NIELSEN A B， SKAARUP K G， DJERNAS K， et al. Left atrial contractile strain predicts recurrence of atrial tachyarrhythmia after catheter ablation ［J］. Int J Cardiol， 2022， 358：51-57. doi:10.1016/j.ijcard.2022.04.056 |
| 34 | LI Y， LI Y， SUN L， et al. Left atrial strain for predicting recurrence in patients with non-valvular atrial fibrillation after catheter ablation： a single-center two-dimensional speckle tracking retrospective study ［J］. BMC Cardiovasc Disord， 2022， 22（1）：468. doi:10.1186/s12872-022-02916-y |
| 35 | KISHEVA A， YOTOV Y. Risk factors for recurrence of atrial fibrillation ［J］. Anatol J Cardiol， 2021， 25（5）： 338-345. |
| 36 | DONG X， MA C， FENG L， et al. Exploration of the Clinical Value and Significance of Body Mass Index， Mean Platelet Volume， and Left Atrial Structural Changes in Recurrence after Radiofrequency Ablation of Atrial Fibrillation ［J］. Altern Ther Health Med， 2023， 29（7）：160-165. |
| 37 | AHN H J， CHA M J， LEE E， et al. The higher recurrence rate after catheter ablation in younger patients with atrial fibrillation suggesting different pathophysiology ［J］. J Interv Card Electrophysiol， 2023， 66（7）：1609-1619. doi:10.1007/s10840-022-01461-0 |
| 38 | ABU-QAOUD M R， KUMAR A， TARUN T， et al. Impact of SGLT2 Inhibitors on AtrialFibrillation Recurrence After Catheter Ablation in Patients WithType-2-Diabetes ［J］. JACC Clin Electrophysiol， 2023， 9（10）：2109-2118. doi:10.1016/j.jacep.2023.06.008 |
/
| 〈 |
|
〉 |